A report saying “fatty liver” describes a finding; it does not provide the complete stage of liver disease or a personal prognosis. The useful next question is how the clinician will assess the risk of scarring and decide what follow-up is needed. This is more informative than buying an extensive liver package solely because an ultrasound report sounds alarming.
Ask whether the appointment is intended to confirm the likely cause of fat in the liver, assess fibrosis risk or review an established liver condition. These questions can overlap, but they are not interchangeable. Bring the original report rather than a translated sentence without the rest of the scan. If several scans exist, keep the dates visible and do not treat different wording as proof that the disease has progressed.
Prepare a record of diabetes or glucose problems, weight changes, cholesterol results, medicines and supplements, and alcohol intake. Give quantities as accurately as you can without trying to make the history sound more acceptable. A useful consultation should consider possible contributing factors and other explanations. Mention previous liver diagnoses and any tests for viral or autoimmune disease already performed, without ordering a fresh panel independently.
NIDDK: Diagnosis of NAFLD & NASH describes the use of blood tests, calculated scores, imaging and, in selected situations, biopsy. Routine imaging showing fat does not by itself establish the extent of inflammation or fibrosis. Ask which risk-assessment step is suitable for you and why. If elastography is suggested, find out what result would lead to monitoring and what result would prompt further evaluation; a device name or a single stiffness number is not a complete plan.
If one report is reassuring and another raises concern, ask the specialist to compare the methods and dates before concluding that one is wrong. Take the full reports, including laboratory reference ranges and technical comments. A second opinion should identify whether the studies answer different questions, whether a result is reliable enough to use and whether another test would actually resolve the uncertainty.
Request a written plan that names what will be monitored, by whom and under which circumstances review should happen earlier. Discuss how liver follow-up will connect with management of any metabolic conditions. Avoid judging progress only by whether a future ultrasound still contains the words “fatty liver.” The clinician should explain the measures relevant to your situation.
For a visit in Turkey, the gastroenterology service information can help route the initial question. Ask whether a liver-focused clinician should assess the documents and confirm which tests are available before arranging travel. New jaundice, marked deterioration or other acute symptoms need prompt local medical assessment; this planned pathway is for a stable patient seeking clarification.
Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.